Literature DB >> 4238577

Cyclophosphamide therapy of Behcet's disease.

C E Buckley, J P Gills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4238577     DOI： 10.1016/0021-8707(69)90148-8

Source DB:  PubMed          Journal:  J Allergy        ISSN： 0021-8707


× No keyword cloud information.
  10 in total

Review 1.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 2.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

3.  [Symptomatology of Behçet's disease (author's transl)].

Authors:  H Schneider
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-07-20

Review 4.  [Inflammatory and systemic reactions of the mouth mucosa].

Authors:  O P Hornstein
Journal:  Arch Otorhinolaryngol       Date:  1976

5.  Severe atypical Behçet's syndrome.

Authors:  D R Park; W C Liles; P Kirby
Journal:  West J Med       Date:  1994-01

Review 6.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Cyclosporine effects on optic nerve and retinal vasculitis in Behçet's disease.

Authors:  P S Chavis; S R Antonios; K F Tabbara
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 8.  Systemic treatment of vitreous inflammation.

Authors:  John B Christoforidis; Susie Chang; Angela Jiang; Jillian Wang; Colleen M Cebulla
Journal:  Mediators Inflamm       Date:  2012-09-16       Impact factor: 4.711

Review 9.  Systemic treatments for noninfectious vitreous inflammation.

Authors:  Angela Jiang; Jillian Wang; Malav Joshi; John Byron Christoforidis
Journal:  Mediators Inflamm       Date:  2013-11-20       Impact factor: 4.711

Review 10.  Systemic therapies for inflammatory eye disease: past, present and future.

Authors:  Alastair K Denniston; Andrew D Dick
Journal:  BMC Ophthalmol       Date:  2013-04-24       Impact factor: 2.209
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.